SWETHA GURAJALA: Open Payments
NPI 1124582036 · FREMONT, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$554 in 10 payments from 7 companies in 2025. Trend: 2023 $2,219 · 2024 $1,379 · 2025 $554
Food & beverage: $554
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $138 |
| Teva Pharmaceuticals USA, Inc. | 1 | $132 |
| AXOGEN | 1 | $103 |
| AstraZeneca Pharmaceuticals LP | 3 | $65 |
| Blueprint Medicines Corporation | 1 | $45 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
| GENZYME CORPORATION | 1 | $32 |
Products named: NUCALA, TEZSPIRE, AYVAKIT, LIBTAYO, DUPIXENT, FASENRA, TRELEGY ELLIPTA.
Industry payments across CA — which companies pay providers there.
